Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?
about
Lamivudine during pregnancy for preventing hepatitis B virus infection in newbornsPegylated interferon for chronic hepatitis BLamivudine for chronic hepatitis B in adultsViruses associated with human cancerEpidemiology and Prevention of Hepatitis B Virus InfectionHepatitis B Reactivation with Novel Agents in Non-Hodgkin's Lymphoma and Prevention StrategiesRole of occult hepatitis B virus infection in chronic hepatitis COccult hepatitis B virus infectionClinical impact of occult hepatitis B virus infection in immunosuppressed patientsHBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markersClinical significance of "anti-HBc alone" in human immunodeficiency virus-positive patientsCurrent hepatitis B virus infection situation in Indonesia and its genetic diversityAsian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipientsRoutine screening of blood donations at Qingdao central blood bank, China, for hepatitis B virus (HBV) DNA with a real-time, multiplex nucleic acid test for HBV, hepatitis C virus, and human immunodeficiency virus Types 1 and 2.Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma.Clinical significance of antibody to hepatitis B core antigen in multitransfused hemodialysis patients.Occult Hepatitis B Virus Infection among HIV Positive Patients in NigeriaOccult hepatitis B virus and hepatocellular carcinomaMolecular characterization of occult hepatitis B virus infection in patients with end-stage liver disease in Colombia.Serological pattern "anti-HBc alone": characterization of 552 individuals and clinical significance.Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.Detection of hepatitis B virus DNA among accepted blood donors in Nanjing, ChinaThe intracellular HBV DNAs as novel and sensitive biomarkers for the clinical diagnosis of occult HBV infection in HBeAg negative hepatocellular carcinoma in China.Risk factors for de novo hepatitis B infection in pediatric living donor liver transplantation.Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance.Spontaneous HBsAg loss in Korean patients: relevance of viral genotypes, S gene mutations, and covalently closed circular DNA copy numbers.Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapyOccult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis CQuantitative detection of hepadnavirus-infected lymphoid cells by in situ PCR combined with flow cytometry: implications for the study of occult virus persistence.Occult hepatitis B virus infection in liver transplant patients in a Brazilian referral centerSignificant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection.Occult hepatitis B virus among the patients with abnormal alanine transaminase.Occult HBV infection among Egyptian hepatocellular carcinoma patients.Trends in prevalence of hepatitis B virus infection among Albanian blood donors, 1999-2009.Occult hepatitis B virus infection and its clinical implications.Prevalence of occult hepatitis B virus infectionHepatitis C virus and other risk factors in hepatocellular carcinoma.Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma.
P2860
Q24235720-CB490D3F-13A5-42AF-8FEB-E54BF0F9891DQ24243530-B3D15CAB-5BDF-4A93-BE26-3F6F91653EBBQ24246121-79EBCC3B-DA42-4D10-B5BA-5FA52C7F1819Q24653900-674C74F4-C31D-4228-9053-2AB53F8CF831Q24810152-95FC701C-4DEE-4F73-AB86-73735C6542CCQ26746486-F3151C14-A44A-411B-B282-284598EED31CQ26823538-AA1CE6E0-BD82-4991-9931-07DB5E48233FQ27004224-E841C12C-63A0-4252-9B6E-FF691866479DQ27006996-45707627-E1ED-4DB2-BB2C-27B7F5038F50Q27478342-79958337-E992-45BF-B363-B8E8AF47506FQ27488236-43C9FA31-9813-4F91-8571-E4B06D1780C9Q28074068-F59834F9-328D-45EB-9A2D-988031A565B5Q30391932-9C073B72-74EE-4B4E-8A52-F8A3207A3386Q30431051-C321FBEF-824B-4E68-AE8C-FB2C26C3C947Q33455459-53A28D96-4734-4F91-93F3-31AC6501C8F6Q33537486-B27E7ADE-4531-4170-91BC-4B2E7162C1F3Q33555339-38249D0E-AD91-4660-A936-AA29C8BA2422Q33560036-2D44D09A-FB33-45D6-ADA4-B047C57283F6Q33607322-5E75068C-AFD2-4E70-85ED-67AD80B4FD18Q33661018-AE2F17E0-D4A4-4CDC-898F-50C972CD82F7Q33883921-05354808-2BDD-4072-8B7A-3629A347184EQ34013180-F0441940-E8E3-46AB-8BCD-59C1B09B5205Q34080966-06D99B7B-FA1F-4240-A6C0-94FF49DEAA8EQ34097882-091A1CF5-DFF4-4EBA-A5D4-ED13C4F8045CQ34206628-BD23593D-F4AF-4C34-AF77-F6B6C7651ED2Q34255573-8A11AB3D-DCE4-4E86-8F87-061125FCF0C8Q34289969-F3E09670-04CA-4BCA-9110-439F87301C02Q34339599-1FF92A68-1B2C-462E-88CC-26C52E454643Q34387913-4859F72B-A244-40D8-A873-B3D1C8E36E51Q34438231-480D4C02-A7D6-4BD4-9A5F-E4067DF21EDAQ34465832-E6D62D6E-35F6-4638-B94C-062688630F1FQ34502631-3CBA11F7-4D09-49C7-B287-C9C10D585597Q34604932-8256B39E-2C7F-48F8-909C-50DEA7507F48Q34628858-ADD138FB-2510-41C3-8AE5-86DE5DC6279FQ34677661-2B830E8C-6083-4170-940F-D656EFF21D9BQ34692987-F790453B-AC18-41B1-A3E9-2BA5C9A05935Q34703532-F4986201-7C27-4D8B-BD3D-A3E91915D637Q34757367-1D7B891C-A12C-4E7E-98F5-33B3FF9DC15AQ34763225-63B64384-F554-43E1-8747-D9294EE377E4Q34785204-8F9599A8-EB79-4F45-A8A9-BFF823823758
P2860
Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Persistent hepatitis B virus i ...... ignificant or purely "occult"?
@ast
Persistent hepatitis B virus i ...... ignificant or purely "occult"?
@en
Persistent hepatitis B virus i ...... ignificant or purely "occult"?
@nl
type
label
Persistent hepatitis B virus i ...... ignificant or purely "occult"?
@ast
Persistent hepatitis B virus i ...... ignificant or purely "occult"?
@en
Persistent hepatitis B virus i ...... ignificant or purely "occult"?
@nl
prefLabel
Persistent hepatitis B virus i ...... ignificant or purely "occult"?
@ast
Persistent hepatitis B virus i ...... ignificant or purely "occult"?
@en
Persistent hepatitis B virus i ...... ignificant or purely "occult"?
@nl
P2093
P356
P1433
P1476
Persistent hepatitis B virus i ...... ignificant or purely "occult"?
@en
P2093
P304
P356
10.1053/JHEP.2001.25172
P407
P577
2001-07-01T00:00:00Z